Two Healthcare Stocks Worth Watching in 2025

Ah, Zoetis (ZTS). It’s the unsung hero of the pet and livestock healthcare world-bringing us drugs, vaccines, and diagnostic tools for everything from your average house cat to your average farm cow. With a portfolio of 17 blockbuster drugs that rake in over $100 million annually, Zoetis is hardly a fly-by-night operation. Still, the stock has seen better days. Since late 2021, its share price has plummeted 40%, thanks largely to a sudden drop in pet adoptions (and yes, we’re blaming the pandemic again).








